The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Leukemia, Nonlymphocytic, Acute

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Leukemia, Nonlymphocytic, Acute


High impact information on Leukemia, Nonlymphocytic, Acute


Chemical compound and disease context of Leukemia, Nonlymphocytic, Acute


Biological context of Leukemia, Nonlymphocytic, Acute


Anatomical context of Leukemia, Nonlymphocytic, Acute


Gene context of Leukemia, Nonlymphocytic, Acute


Analytical, diagnostic and therapeutic context of Leukemia, Nonlymphocytic, Acute


  1. Phase I and pharmacokinetic trial of carboplatin in refractory adult leukemia. Lee, E.J., Egorin, M.J., Van Echo, D.A., Cohen, A.E., Tait, N., Schiffer, C.A. J. Natl. Cancer Inst. (1988) [Pubmed]
  2. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. Pedersen-Bjergaard, J., Ersbøll, J., Sørensen, H.M., Keiding, N., Larsen, S.O., Philip, P., Larsen, M.S., Schultz, H., Nissen, N.I. Ann. Intern. Med. (1985) [Pubmed]
  3. Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia. Lee, E.J., Van Echo, D.A., Egorin, M.J., Nayar, M.S., Shulman, P., Schiffer, C.A. Blood (1986) [Pubmed]
  4. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Tutschka, P.J., Copelan, E.A., Klein, J.P. Blood (1987) [Pubmed]
  5. Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission. Adler, A., Chervenick, P.A., Whiteside, T.L., Lotzová, E., Herberman, R.B. Blood (1988) [Pubmed]
  6. Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. Fialkow, P.J., Singer, J.W., Raskind, W.H., Adamson, J.W., Jacobson, R.J., Bernstein, I.D., Dow, L.W., Najfeld, V., Veith, R. N. Engl. J. Med. (1987) [Pubmed]
  7. Low-dose cytarabine: persistence of a clonal abnormality during complete remission of acute nonlymphocytic leukemia. Tilly, H., Bastard, C., Bizet, M., Piguet, H., Castaigne, S., Degos, L. N. Engl. J. Med. (1986) [Pubmed]
  8. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. Yeager, A.M., Kaizer, H., Santos, G.W., Saral, R., Colvin, O.M., Stuart, R.K., Braine, H.G., Burke, P.J., Ambinder, R.F., Burns, W.H. N. Engl. J. Med. (1986) [Pubmed]
  9. Carmustine as a cause of acute nonlymphocytic leukemia. Greene, M.H., Boice, J.D., Strike, T.A. N. Engl. J. Med. (1985) [Pubmed]
  10. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. Santos, G.W., Tutschka, P.J., Brookmeyer, R., Saral, R., Beschorner, W.E., Bias, W.B., Braine, H.G., Burns, W.H., Elfenbein, G.J., Kaizer, H. N. Engl. J. Med. (1983) [Pubmed]
  11. Therapy of secondary acute nonlymphocytic leukemia with cytarabine. Preisler, H.D., Early, A.P., Raza, A., Vlahides, G., Marinello, M.J., Stein, A.M., Browman, G. N. Engl. J. Med. (1983) [Pubmed]
  12. All patients with acute nonlymphocytic leukemia may have a chromosomal defect. Yunis, J.J., Bloomfield, C.D., Ensrud, K. N. Engl. J. Med. (1981) [Pubmed]
  13. Risk of leukemia following treatment for non-Hodgkin's lymphoma. Travis, L.B., Curtis, R.E., Stovall, M., Holowaty, E.J., van Leeuwen, F.E., Glimelius, B., Lynch, C.F., Hagenbeek, A., Li, C.Y., Banks, P.M. J. Natl. Cancer Inst. (1994) [Pubmed]
  14. Chloramphenicol use and childhood leukaemia in Shanghai. Shu, X.O., Gao, Y.T., Linet, M.S., Brinton, L.A., Gao, R.N., Jin, F., Fraumeni, J.F. Lancet (1987) [Pubmed]
  15. Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients. Cuneo, A., Mecucci, C., Kerim, S., Vandenberghe, E., Dal Cin, P., Van Orshoven, A., Rodhain, J., Bosly, A., Michaux, J.L., Martiat, P. Blood (1989) [Pubmed]
  16. Evidence favoring lineage fidelity in acute nonlymphocytic leukemia: absence of immunoglobulin gene rearrangements in FAB types M4 and M5. Ackland, S.P., Westbrook, C.A., Diaz, M.O., Le Beau, M.M., Rowley, J.D. Blood (1987) [Pubmed]
  17. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. van der Reijden, B.A., Lombardo, M., Dauwerse, H.G., Giles, R.H., Mühlematter, D., Bellomo, M.J., Wessels, H.W., Beverstock, G.C., van Ommen, G.J., Hagemeijer, A. Blood (1995) [Pubmed]
  18. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer. Tan, C.T., Hancock, C.H., Mondora, A., Hoffman, N.W. Cancer Res. (1984) [Pubmed]
  19. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience. Koletsky, A.J., Bertino, J.R., Farber, L.R., Prosnitz, L.R., Kapp, D.S., Fischer, D., Portlock, C.S. J. Clin. Oncol. (1986) [Pubmed]
  20. Characterization of a factor-dependent acute leukemia cell line with translocation (3;3)(q21;q26). Oval, J., Jones, O.W., Montoya, M., Taetle, R. Blood (1990) [Pubmed]
  21. Thymidine as a chemotherapeutic agent: sensitivity of normal human marrow, peripheral blood T cells, and acute nonlymphocytic leukemia. Howell, S.B., Taetle, R., Mendelsohn, J. Blood (1980) [Pubmed]
  22. Heterogeneity of B cell involvement in acute nonlymphocytic leukemia. Ferraris, A.M., Raskind, W.H., Bjornson, B.H., Jacobson, R.J., Singer, J.W., Fialkow, P.J. Blood (1985) [Pubmed]
  23. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia. Rowley, S.D., Jones, R.J., Piantadosi, S., Braine, H.G., Colvin, O.M., Davis, J., Saral, R., Sharkis, S., Wingard, J., Yeager, A.M. Blood (1989) [Pubmed]
  24. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Le Beau, M.M., Lemons, R.S., Espinosa, R., Larson, R.A., Arai, N., Rowley, J.D. Blood (1989) [Pubmed]
  25. Human cytosolic and mitochondrial folylpolyglutamate synthetase are electrophoretically distinct. Expression in antifolate-sensitive and -resistant human cell lines. McGuire, J.J., Russell, C.A., Balinska, M. J. Biol. Chem. (2000) [Pubmed]
  26. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis. Archimbaud, E., Thomas, X., Campos, L., Magaud, J.P., Doré, J.F., Fiere, D. Leukemia (1992) [Pubmed]
  27. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry. Larson, R.S., McCurley, T.L. Am. J. Clin. Pathol. (1995) [Pubmed]
  28. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse. Rosenfeld, C., Shadduck, R.K., Przepiorka, D., Mangan, K.F., Colvin, M. Blood (1989) [Pubmed]
  29. Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study. Preisler, H., Davis, R.B., Kirshner, J., Dupre, E., Richards, F., Hoagland, H.C., Kopel, S., Levy, R.N., Carey, R., Schulman, P. Blood (1987) [Pubmed]
  30. Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors. Bostrom, B., Brunning, R.D., McGlave, P., Ramsay, N., Nesbit, M., Woods, W.G., Hurd, D., Krivit, W., Kim, T., Goldman, A. Blood (1985) [Pubmed]
  31. DNA ligation in relation to DNA strand breaks in phytohemagglutinin-stimulated blast cells from acute lymphoblastic and nonlymphoblastic leukemia. Feon, S.A., Valerius, R.M., Genetet, N.M., Bernard-Griffiths, I., Le Prise, P.Y., Le Gall, E.J., David, J.C. Blood (1988) [Pubmed]
  32. Cell kinetic responses in childhood acute nonlymphocytic leukemia during high-dose therapy with cytosine arabinoside. Smets, L.A., Taminiau, J., Hählen, K., de Waal, F., Behrendt, H. Blood (1983) [Pubmed]
WikiGenes - Universities